Cardiovascular Health

"Bad Cholesterol": Good Marketing, But Is It Good Medicine?

By Cleaves M. Bennett, MD | Contributing Writer - Vol. 8, No. 3. Fall, 2007

The cholesterol model of heart disease, which labels LDL as “bad” and HDL as “good,” has certainly helped drug companies sell a lot of statin medications. But has it really reduced the impact of obesity, heart disease and diabetes in this country? “Not really,” says Dr. Cleaves Bennett, one of the nation’s leading experts on hypertension, kidney disease and preventive medicine.

D, C and CVD: New Studies Correlate Deficiencies With Cardiovascular Risk

By August West | Contributing Writer - Vol. 9, No. 1. Spring, 2008

Two new studies provide fresh data showing that deficiencies in vitamin D and vitamin C are strongly associated with increased risk of myocardial infarction and stroke. The big-and still unanswered question---is whether supplementing with these vitamins will reduce that risk.

Digital Pulse Wave Analysis Offers Non-Invasive Early Heart Risk Assessment

By August West | Contributing Writer - Vol. 10, No. 2. Summer, 2009

Central Aortic Systolic Pressure (CASP) is one of the most powerful early predictors of cardiovascular risk. New digital pulse wave analysis technology is putting this valuable test in the hands of preventive primary care doctors.

Home Sleep Monitoring Opens Gateway for Better Apnea Control

By Lee A. Surkin MD, FACC, FCCP | Contributing Writer - Vol. 10, No. 1. Spring, 2009

Sleep apnea is common, debilitating and sometimes deadly. In the past, diagnosis involved costly sleep labs. New home monitoring devices provide greater patient comfort, save money, and generate revenue for primary care. Dr. Lee Surkin shares his clinical experience.

JUPITER: Separating the Solid Clinical Matter From the Hot Gas

By August West | Contributing Writer - Vol. 9, No. 4. Winter, 2008

Gaseous Surface of Jupiter: Many cardiologists are hailing the massive JUPITER trial as a breakthrough, claiming that statin therapy could reduce cardiovascular risk even in patients with normal LDL.

IDA Medical Foundation Seeks to "Democratize" Prevention

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 4. Winter, 2008

Cutting edge early risk detection tests and preventive medicine have become the privilege of the wealthy. Dr. James Ehrlich, a pioneer in cardiovascular risk assessment, hopes to change that with his new Identify Disease in Advance Foundation, which will bring state-of-the-art preventive medicine to people who can least afford it but would most benefit from it.

GGT: An Accurate, Inexpensive Predictor of Cardiometabolic Risk

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 4. Winter, 2008

Gamma glutamyl transferase (GGT) is a hepatic enzyme that indicates levels of oxidative stress in the liver. A large body of research suggests that it can also predict onset of insulin resistance, type 2 diabetes, and cardiovascular disease. At under $10 per test, it could be a very valuable asset in clinical practice.

"NO" News is Good News: Nitric Oxide for CVD & Diabetes

By Tamara Sofi-Smith, PhD candidate | Contributing Writer - Vol. 9, No. 4. Winter, 2008

"From diabetes to hypertension, cancer to drug addiction, stroke to intestinal motility, memory and learning disorders to septic shock, sunburn to anorexia, male impotence to tuberculosis, there is probably no pathological condition where nitric oxide does not play an important role."

Chronic Fatigue, Cardiomyopathy & Oxidative Stress: New Thinking Opens New Approaches

By Allison Templet | Contributing Writer - Vol. 9, No. 3. Fall, 2008

Chronic fatigue syndrome (CFS), one of the most vexing conditions for patients and doctors alike, reflects a state of oxygen toxicity, and management of oxidative stress appears to be a key to reversing the fatigue, pain, and neuropsychological complaints associated with this disorder, says Paul R. Cheney, MD, PhD, a pioneer in the clinical research of CFS.

Metabolic Cardiology: Solving the Heart's Energy Crisis

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 2. Summer, 2008

A new vanguard of "metabolic" cardiologists contends that cholesterol elevation has been overstated as a cause of heart disease, and that physicians should pay more attention to the heart muscle itself. A quartet of nutrients magnesium, co-enzyme Q10, L-carnitine, and D-ribose can profoundly improve the heart's pumping ability and reduce risk of death, even in very ill patients.